Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Gibbs

Showing results (501-510 of 515) with videos related to

Pageof 52
Sort By:
Oncogene|October 23, 2012
Different APC genotypes in proximal and distal sporadic colorectal cancers suggest distinct WNT/β-catenin signalling thresholds for tumourigenesisM Christie, R N Jorissen, D Mouradov, et al.
Cancer Research Communications|October 24, 2025
A First-In-Human Study of the SUMOylation Inhibitor Subasumstat in Patients with Advanced/Metastatic Solid Tumors or Relapsed/Refractory Hematologic MalignanciesDejan Juric, Daniel Anderson, Afshin Dowlati, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 29, 2019
Circulating tumor DNA as a potential marker of adjuvant chemotherapy benefit following surgery for localized pancreatic cancerB Lee, L Lipton, J Cohen, et al.
International Journal of Epidemiology|August 13, 2022
Association between household composition and severe COVID-19 outcomes in older people by ethnicity: an observational cohort study using the OpenSAFELY platformKevin Wing, Daniel J Grint, Rohini Mathur, et al.
Human Gene Therapy. Clinical Development|June 6, 2018
Gene Therapy for Osteoarthritis: Pharmacokinetics of Intra-Articular Self-Complementary Adeno-Associated Virus Interleukin-1 Receptor Antagonist Delivery in an Equine ModelRachael S Watson Levings, Ted A Broome, Andrew D Smith, et al.
Human Gene Therapy. Clinical Development|June 6, 2018
Self-Complementary Adeno-Associated Virus-Mediated Interleukin-1 Receptor Antagonist Gene Delivery for the Treatment of Osteoarthritis: Test of Efficacy in an Equine ModelRachael S Watson Levings, Andrew D Smith, Ted A Broome, et al.
Cancer Research Communications|November 26, 2025
Phase 1b Study of Dazostinag plus Pembrolizumab after Hypofractionated Radiotherapy in Patients with Select Advanced Solid TumorsBenjamin T Cooper, Wade T Iams, David B Page, et al.
Journal of Neuro-Oncology|April 17, 2024
Exploring management and outcomes of elderly patients with glioblastoma using data from two randomised trials (GEINO1401/EX-TEM)Lucy Gately, C Mesía, J M Sepúlveda, et al.
Journal of Neuro-Oncology|December 28, 2023
A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastomaL Gately, C Mesía, J M Sepúlveda, et al.
Journal of Neuro-Oncology|January 30, 2024
Correction to: A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastomaL Gately, C Mesía, J M Sepúlveda, et al.
Pageof 52

Showing results (501-510 of 515) with videos related to

Sort By:
Pageof 52
Oncogene|October 23, 2012
Different APC genotypes in proximal and distal sporadic colorectal cancers suggest distinct WNT/β-catenin signalling thresholds for tumourigenesisM Christie, R N Jorissen, D Mouradov, et al.
Cancer Research Communications|October 24, 2025
A First-In-Human Study of the SUMOylation Inhibitor Subasumstat in Patients with Advanced/Metastatic Solid Tumors or Relapsed/Refractory Hematologic MalignanciesDejan Juric, Daniel Anderson, Afshin Dowlati, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 29, 2019
Circulating tumor DNA as a potential marker of adjuvant chemotherapy benefit following surgery for localized pancreatic cancerB Lee, L Lipton, J Cohen, et al.
International Journal of Epidemiology|August 13, 2022
Association between household composition and severe COVID-19 outcomes in older people by ethnicity: an observational cohort study using the OpenSAFELY platformKevin Wing, Daniel J Grint, Rohini Mathur, et al.
Human Gene Therapy. Clinical Development|June 6, 2018
Gene Therapy for Osteoarthritis: Pharmacokinetics of Intra-Articular Self-Complementary Adeno-Associated Virus Interleukin-1 Receptor Antagonist Delivery in an Equine ModelRachael S Watson Levings, Ted A Broome, Andrew D Smith, et al.
Human Gene Therapy. Clinical Development|June 6, 2018
Self-Complementary Adeno-Associated Virus-Mediated Interleukin-1 Receptor Antagonist Gene Delivery for the Treatment of Osteoarthritis: Test of Efficacy in an Equine ModelRachael S Watson Levings, Andrew D Smith, Ted A Broome, et al.
Cancer Research Communications|November 26, 2025
Phase 1b Study of Dazostinag plus Pembrolizumab after Hypofractionated Radiotherapy in Patients with Select Advanced Solid TumorsBenjamin T Cooper, Wade T Iams, David B Page, et al.
Journal of Neuro-Oncology|April 17, 2024
Exploring management and outcomes of elderly patients with glioblastoma using data from two randomised trials (GEINO1401/EX-TEM)Lucy Gately, C Mesía, J M Sepúlveda, et al.
Journal of Neuro-Oncology|December 28, 2023
A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastomaL Gately, C Mesía, J M Sepúlveda, et al.
Journal of Neuro-Oncology|January 30, 2024
Correction to: A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastomaL Gately, C Mesía, J M Sepúlveda, et al.
Pageof 52